Provided by Tiger Fintech (Singapore) Pte. Ltd.

Heron Therapeutics

2.20
+0.05002.33%
Post-market: 2.230.0400+1.83%19:55 EDT
Volume:1.38M
Turnover:3.14M
Market Cap:335.13M
PE:-24.70
High:2.38
Open:2.24
Low:2.19
Close:2.15
Loading ...

Heron Therapeutics Inc: Outlook FY Net REV $153.0 Mln to $163.0 Mln

THOMSON REUTERS
·
27 Feb

Heron Therapeutics Q4 Net Income USD 3.663 Million

THOMSON REUTERS
·
27 Feb

Heron Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Updates

PR Newswire
·
27 Feb

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
27 Feb

Heron Therapeutics Inc expected to post a loss of 3 cents a share - Earnings Preview

Reuters
·
25 Feb

Heron Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results On Thursday, February 27, 2025

PR Newswire
·
14 Feb

Heron Therapeutics, Inc. (NASDAQ:HRTX) is a favorite amongst institutional investors who own 58%

Simply Wall St.
·
21 Jan

Heron Therapeutics Relocates Corporate Headquarters to Cary, North Carolina to Join Growing Biotech Community

MT Newswires Live
·
24 Dec 2024

BRIEF-Heron Therapeutics Announces Corporate Headquarters Relocation To Cary, North Carolina

Reuters
·
24 Dec 2024

Heron Therapeutics Relocates Headquarters to North Carolina

TIPRANKS
·
24 Dec 2024

Heron Therapeutics relocates corporate headquarters to Cary, North Carolina

TIPRANKS
·
24 Dec 2024

Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina

THOMSON REUTERS
·
24 Dec 2024

Heron Therapeutics Announces Corporate Headquarters Relocation to Cary, North Carolina

PR Newswire
·
24 Dec 2024

Exploring Three High Growth Tech Stocks In The United States

Simply Wall St.
·
12 Dec 2024

Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN), Arrowhead Pharmaceuticals (ARWR) and Heron Therapeutics (HRTX)

TIPRANKS
·
06 Dec 2024

Heron Therapeutics Shares up 47% After U.S. District Court Ruled in Co's Favor in Patent Litigation Against Fresenius Kabi USA

THOMSON REUTERS
·
04 Dec 2024

Sector Update: Health Care Stocks Steady Pre-Bell Wednesday

MT Newswires Live
·
04 Dec 2024

Traders Await Powell Comments as US Equity Futures Post Premarket Gains

MT Newswires Live
·
04 Dec 2024

Heron Therapeutics patent victory removes ‘major overhang,’ says Northland

TIPRANKS
·
04 Dec 2024

Heron Therapeutics Price Target Maintained With a $4.00/Share by Needham

Dow Jones
·
04 Dec 2024